| 7772425 |
Vitamin D receptor modulators |
Emilio Bunel, Robert P. Gajewski, Jianliang Lu, Tianwei Ma, Sunil Nagpal +1 more |
2010-08-10 |
$52,045,000 |
| 7750184 |
Vitamin D receptor modulators |
Robert P. Gajewski, Jared Harris Linebarger, Jianliang Lu, Tianwei Ma, Sunil Nagpal +1 more |
2010-07-06 |
$85,250,000 |
| 7601850 |
Phenyl-thiophene type vitamin D receptor modulators |
Karl Robert Dahnke, Robert P. Gajewski, Jared Harris Linebarger, Jianliang Lu, Tianwei Ma +5 more |
2009-10-13 |
$124,907,000 |
| 7595345 |
Vitamin D receptor modulators |
Emilio Bunel, Robert P. Gajewski, Jianliang Lu, Sunil Nagpal, Tianwei Ma +1 more |
2009-09-29 |
$67,969,000 |
| 7501441 |
Naphthyl compounds, intermediates, processes, compositions, and methods |
Henry U. Bryant, George J. Cullinan, Jeffrey A. Dodge, Kennan J. Fahey, Charles Willis Lugar, III +1 more |
2009-03-10 |
$203,125,000 |
| 7468449 |
Phenyl-furan compounds as vitamin D receptor modulators |
Robert P. Gajewski, Jianliang Lu, Tianwei Ma, Sunil Nagpal, Ying Kwong Yee |
2008-12-23 |
$293,764,000 |
| 7105541 |
Naphthyl compounds, intermediates, compositions, and methods of use |
Thomas Alan Crowell |
2006-09-12 |
$216,160,000 |
| 6812244 |
Naphthyl compounds, intermediates, compositions, and methods of use |
Henry U. Bryant, Thomas Alan Crowell, Alan David Palkowitz |
2004-11-02 |
$322,095,000 |
| 6703407 |
Benzofuran compounds, compositions, and methods |
Henry U. Bryant, George J. Cullinan, Jeffrey A. Dodge, Kennan J. Fahey |
2004-03-09 |
$149,189,000 |
| 6686372 |
Selective &bgr;3 adrenergic agonists |
Thomas Alan Crowell, Deborah A. Evrard, Brian S. Muehl, Christopher J. Rito, Anthony John Shuker +2 more |
2004-02-03 |
$162,745,000 |
| 6617347 |
Selective &bgr;3 adrenergic agonists |
Thomas Alan Crowell, Anthony John Shuker |
2003-09-09 |
$63,645,000 |
| 6608090 |
Benzothiophenes with novel basic side chains |
Michelle L. Bourgeois, Jeffrey A. Dodge |
2003-08-19 |
$152,467,000 |
| 6599920 |
Naphthalene compounds, intermediates, formulations, and methods |
Henry U. Bryant, Thomas Alan Crowell |
2003-07-29 |
$468,870,000 |
| 6593345 |
Naphthyl compounds, intermediates, compositions, and methods of use |
Henry U. Bryant, Thomas Alan Crowell, Alan David Palkowitz |
2003-07-15 |
$528,876,000 |
| 6444688 |
Compounds and compositions with nitrogen-containing non-basic side chains |
Jeffrey A. Dodge, Kristin Marron, James P. Sluka, Mark Stocksdale |
2002-09-03 |
$141,811,000 |
| 6440958 |
Acrylic and propionic acid compounds, intermediates, processes, compositions, and methods |
Alan David Palkowitz, Kenneth Jeff Thrasher |
2002-08-27 |
$211,063,000 |
| 6437137 |
Naphthyl compounds, intermediates, processes, compositions, and methods |
Henry U. Bryant, George J. Cullinan, Jeffrey A. Dodge, Kennan J. Fahey, Charles Willis Lugar, III +1 more |
2002-08-20 |
$92,904,000 |
| 6413991 |
Selective &bgr;3 adrenergic agonists |
Thomas Alan Crowell, Deborah A. Evrard, Brian S. Muehl, Christopher J. Rito, Anthony John Shuker +2 more |
2002-07-02 |
$313,924,000 |
| 6410564 |
Naphthyl compounds, intermediates, processes, compositions, and methods |
Henry U. Bryant, George J. Cullinan, Jeffrey A. Dodge, Kennan J. Fahey, Charles Willis Lugar, III +1 more |
2002-06-25 |
$96,892,000 |
| 6407243 |
Benzofuran compounds, compositions, and methods |
Henry U. Bryant, George J. Cullinan, Jeffrey A. Dodge, Kennan J. Fahey |
2002-06-18 |
$190,659,000 |
| 6399634 |
Benzothiophene compounds, compositions, and methods |
Henry U. Bryant, George J. Cullinan, Jeffrey A. Dodge, Kennan J. Fahey |
2002-06-04 |
$122,963,000 |
| 6350884 |
Acrylic and propionic acid compounds, intermediates, processes, compositions, and method |
Alan David Palkowitz, Kenneth Jeff Thrasher |
2002-02-26 |
$168,169,000 |
| 6232337 |
Selective .beta.3 adrenergic agonists |
Thomas Alan Crowell, Anthony John Shuker |
2001-05-15 |
$406,429,000 |
| 6140352 |
Carbazolyl-substituted ethanolamines as selective .beta.-.sub.3 agonists |
Thomas Alan Crowell, Deborah A. Evrard, Brian S. Muehl, Christopher J. Rito, Anthony John Shuker +2 more |
2000-10-31 |
$630,376,000 |
| 6046227 |
Selective .beta.3 adrenergic agonists |
Thomas Alan Crowell, Anthony John Shuker |
2000-04-04 |
$216,653,000 |
